In fact, Conde-Pueyo et al. suggest that TUBB6 forms a sythetic lethal (SL) association with the cancer-related gene BUB1, speculating that treatments targeting the tubulin gene should be more efficient in cancers where BUB1 is mutated [42]. The gene discussed is BUB1; the disease is cancer.